View Prothena Corp. Plc PRTA stock quote prices, financial information, real-time forecasts, and company news from CNN.
Prothena ( (PRTA)) has issued an update. On May 14, 2026, Prothena shareholders re-elected directors Shane M. Cooke and Dennis J. Selkoe to the board to serve until no later than the 2029 annual ...
RBC Capital analyst Brian Abrahams maintained a Hold rating on Prothena yesterday and set a price target of $13.00. Abrahams covers the Healthcare sector, focusing on stocks such as Gilead Sciences, ...
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today reported ...
Net cash provided by operating and investing activities was $28.9 million for the first quarter of 2026; quarter-end cash and restricted cash position was $330.3 million Prothena updates projected ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
DUBLIN--(BUSINESS WIRE)--$PRTA #Prothena--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results